THE CHALLENGE OF HIV VACCINES

被引:3
作者
GIRARD, M
机构
关键词
D O I
10.1016/0264-410X(91)90211-N
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Immunization of an animal or human being against an infections agent provides levels of protection that are relative only. Protection can be overcome by high challenge doses. Even with a low challenge dose, protection can vary from absolute to relative. The invading pathogen may be neutralized and eliminated from the body before it can multiply; in this case, immunization provides protection against infection. More frequently, the infectious agent starts multiplying at the site of entry, which triggers an anamnestic immune response of the host. Rejection of the invader usually takes place before the appearance of overt clinical symptoms; in this case, immunization provides protection against disease. Protection against infection implies a strong pre-existing immune barrier. Protection against disease mostly relies on immune memory and the possibility for the host of mounting a rapid immune response against the infectious agent.
引用
收藏
页码:781 / 783
页数:3
相关论文
共 14 条
[1]   EFFECT OF DOSE AND IMMUNIZATION SCHEDULE ON IMMUNE-RESPONSE OF BABOONS TO RECOMBINANT GLYCOPROTEIN-120 OF HIV-1 [J].
ANDERSON, KP ;
LUCAS, C ;
HANSON, CV ;
LONDE, HF ;
IZU, A ;
GREGORY, T ;
AMMANN, A ;
BERMAN, PW ;
EICHBERG, JW .
JOURNAL OF INFECTIOUS DISEASES, 1989, 160 (06) :960-969
[2]   PROTECTION OF CHIMPANZEES FROM INFECTION BY HIV-1 AFTER VACCINATION WITH RECOMBINANT GLYCOPROTEIN GP120 BUT NOT GP160 [J].
BERMAN, PW ;
GREGORY, TJ ;
RIDDLE, L ;
NAKAMURA, GR ;
CHAMPE, MA ;
PORTER, JP ;
WURM, FM ;
HERSHBERG, RD ;
COBB, EK ;
EICHBERG, JW .
NATURE, 1990, 345 (6276) :622-625
[3]  
CORDONNIER A, 1989, 4EME C CENT GARD, P129
[4]   ANTIBODY-MEDIATED INVITRO NEUTRALIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ABOLISHES INFECTIVITY FOR CHIMPANZEES [J].
EMINI, EA ;
NARA, PL ;
SCHLEIF, WA ;
LEWIS, JA ;
DAVIDE, JP ;
LEE, DR ;
KESSLER, J ;
CONLEY, S ;
MATSUSHITA, S ;
PUTNEY, SD ;
GERETY, RJ ;
EICHBERG, JW .
JOURNAL OF VIROLOGY, 1990, 64 (08) :3674-3678
[5]   WOMEN, HIV, AND MUCOSAL IMMUNITY [J].
FORREST, BD .
LANCET, 1991, 337 (8745) :835-836
[6]   IMMUNIZATION OF CHIMPANZEES CONFERS PROTECTION AGAINST CHALLENGE WITH HUMAN-IMMUNODEFICIENCY-VIRUS [J].
GIRARD, M ;
KIENY, MP ;
PINTER, A ;
BARRESINOUSSI, F ;
NARA, P ;
KOLBE, H ;
KUSUMI, K ;
CHAPUT, A ;
REINHART, T ;
MUCHMORE, E ;
RONCO, J ;
KACZOREK, M ;
GOMARD, E ;
GLUCKMAN, JC ;
FULTZ, PN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (02) :542-546
[7]  
GIRARD M P, 1990, AIDS (London), V4, pS143
[8]   SEQUENTIAL IMMUNIZATIONS WITH RGP120S FROM INDEPENDENT ISOLATES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INDUCE THE PREFERENTIAL EXPANSION OF BROADLY CROSS-REACTIVE B-CELLS [J].
KLINMAN, DM ;
HIGGINS, KW ;
CONOVER, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (04) :881-887
[9]   DELINEATION OF A REGION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 GLYCOPROTEIN CRITICAL FOR INTERACTION WITH THE CD4 RECEPTOR [J].
LASKY, LA ;
NAKAMURA, G ;
SMITH, DH ;
FENNIE, C ;
SHIMASAKI, C ;
PATZER, E ;
BERMAN, P ;
GREGORY, T ;
CAPON, DJ .
CELL, 1987, 50 (06) :975-985
[10]   HIV-1 - THE INFECTIVE PROCESS INVIVO [J].
MCCUNE, JM .
CELL, 1991, 64 (02) :351-363